Fibrocell Science Inc.
FCSC
FCSC was delisted on the 12th of December, 2019.
52 hedge funds and large institutions have $75.4M invested in Fibrocell Science Inc. in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 16 closing their positions.
36% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 11
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 58 → 52 (-6)
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
48% less capital invested
Capital invested by funds: $145M → $75.4M (-$69.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.36M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$420K |
| 3 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$298K |
| 4 |
State Street
Boston,
Massachusetts
|
+$164K |
| 5 |
MP
MSD Partners
New York
|
+$155K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$2.41M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.92M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$1.48M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.25M |
| 5 |
ACM
Akanthos Capital Management
Woodland Hills,
California
|
-$257K |
FCSC Hedge Fund Activity: Q1 2016 in Review
52 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q1 2016, worth a combined $75.4M — down 48% from $145M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of FCSC and 10 opened new positions — a net loss of 6 holders — while 11 trimmed existing stakes and 15 added.
The largest buyer was Vanguard Group, adding an estimated $1.36M. The largest seller was Jennison Associates, cutting an estimated $2.41M.
- 52 institutional investors held Fibrocell Science Inc. (FCSC) as of Q1 2016, down from 58 in Q4 2015.
- Funds reported $75.4M of Fibrocell Science Inc. stock for Q1 2016, down 48% quarter-over-quarter.
- 10 funds opened new Fibrocell Science Inc. positions in Q1 2016 and 16 closed out, a net change of -6 holders.
- The largest Fibrocell Science Inc. buyer in Q1 2016 was Vanguard Group, an estimated $1.36M added.
- The largest Fibrocell Science Inc. seller in Q1 2016 was Jennison Associates, an estimated $2.41M sold.
Based on aggregated 13F filings for Q1 2016.